Skip to main content

EUbOPEN logo

European Federation of Pharmaceutical Industries and AssociationsInnovative Medicines InitiativeEuropean Commission Research and Innovation logo

  • About
    • Management Team
  • Collaborate
    • Diamond XChem Fragment screening
    • Contact us
  • Data Gateway
  • Protocols
    • Chemical probes
    • Chemical handles
  • Chemogenomics
    • Chemogenomics criteria
    • Chemogenomic set
  • Antibodies
  • Tissue Assays
  • News & Events
  • Publications

Protocols & Reagents

Download

  • Protocol for NanoBRET assay
  • Protocol for HPLC
  • Protocol for DSF
  • Protocol for Multiplexed Cytotox Assay
  • Protocol for GPCR Selectivity Profiling & Supplemental Information
  • Protocol for DNA Glycolysases
  • Protocol for Malachite Green
  • Protocol for Hybrid Reporter Gene Assay
  • Protocol for LiP-MS
  • Protocol for cell-based biosensor transport assay
  • Protocol for generation of normal and tumor organoids from human colorectal tissues
  • Protocol for generation and culture of CRC fibroblasts
  • Protocol for lentiviral transduction of CRC organoids and CAFs
  • Protocol for NanoLuc and HiBIT CETSA assays
  • HTRF assay for YEATS domain peptide interaction
  • Protocol for in vitro tissue platforms
  • Protocol for Raman spectral analysis
  • Protocol for HTSynthesis
The EUbOPEN project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 875510. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme, EFPIA companies and Associated Partners: KTH, OICR, Diamond and McGill. This communication reflects the views of the authors and neither IMI nor the European Union, EFPIA or any Associated Partners are liable for any use that may be made of the information contained herein.
 
This website is licensed under a CC-BY licence | Privacy statement | Accessibility